Literature DB >> 28373583

Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection.

Rudragouda Channappanavar1, Craig Fett1, Matthias Mack2, Patrick P Ten Eyck3, David K Meyerholz4, Stanley Perlman5.   

Abstract

Pathogenic human coronaviruses (CoVs), such as the severe acute respiratory syndrome (SARS)-CoV and the Middle East respiratory syndrome-CoV, cause acute respiratory illness. Epidemiological data from the 2002-2003 SARS epidemic and recent Middle East respiratory syndrome outbreak indicate that there may be sex-dependent differences in disease outcomes. To investigate these differences, we infected male and female mice of different age groups with SARS-CoV and analyzed their susceptibility to the infection. Our results showed that male mice were more susceptible to SARS-CoV infection compared with age-matched females. The degree of sex bias to SARS-CoV infection increased with advancing age, such that middle-aged mice showed much more pronounced differences compared with young mice. Enhanced susceptibility of male mice to SARS-CoV was associated with elevated virus titers, enhanced vascular leakage, and alveolar edema. These changes were accompanied by increased accumulation of inflammatory monocyte macrophages and neutrophils in the lungs of male mice, and depletion of inflammatory monocyte macrophages partially protected these mice from lethal SARS. Moreover, the sex-specific differences were independent of T and B cell responses. Furthermore, ovariectomy or treating female mice with an estrogen receptor antagonist increased mortality, indicating a protective effect for estrogen receptor signaling in mice infected with SARS-CoV. Together, these data suggest that sex differences in the susceptibility to SARS-CoV in mice parallel those observed in patients and also identify estrogen receptor signaling as critical for protection in females.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28373583      PMCID: PMC5450662          DOI: 10.4049/jimmunol.1601896

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 2.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages.

Authors:  Amy J Murphy; Paul M Guyre; Patricia A Pioli
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

4.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.

Authors:  Yong Jiang; Jun Xu; Chengzhi Zhou; Zhenguo Wu; Shuqing Zhong; Jinghua Liu; Wei Luo; Tao Chen; Qinghe Qin; Peng Deng
Journal:  Am J Respir Crit Care Med       Date:  2005-01-18       Impact factor: 21.405

5.  Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice.

Authors:  Jincun Zhao; Jingxian Zhao; Kevin Legge; Stanley Perlman
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

Review 6.  The effects of hormones on sex differences in infection: from genes to behavior.

Authors:  S L Klein
Journal:  Neurosci Biobehav Rev       Date:  2000-08       Impact factor: 8.989

7.  The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

Authors:  Chris J Malkin; Peter J Pugh; Richard D Jones; Dheeraj Kapoor; Kevin S Channer; T Hugh Jones
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

8.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

9.  Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity.

Authors:  Jennifer A Rettew; Yvette M Huet-Hudson; Ian Marriott
Journal:  Biol Reprod       Date:  2007-11-14       Impact factor: 4.285

Review 10.  The complex role of estrogens in inflammation.

Authors:  Rainer H Straub
Journal:  Endocr Rev       Date:  2007-07-19       Impact factor: 19.871

View more
  297 in total

1.  Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank.

Authors:  Zahra Raisi-Estabragh; Celeste McCracken; Mae S Bethell; Jackie Cooper; Cyrus Cooper; Mark J Caulfield; Patricia B Munroe; Nicholas C Harvey; Steffen E Petersen
Journal:  J Public Health (Oxf)       Date:  2020-08-18       Impact factor: 2.341

2.  Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China.

Authors:  Na Shen; Yaowu Zhu; Xiong Wang; Jing Peng; Weiyong Liu; Feng Wang; Yanjun Lu; Liming Cheng; Ziyong Sun
Journal:  JCI Insight       Date:  2020-05-21

Review 3.  COVID-19 in Africa: an ovarian victory?

Authors:  Osman A Dufailu; Afrakoma Afriyie-Asante; Bernard Gyan; David Adu Kwabena; Helena Yeboah; Frank Ntiakoh; Meshach Asare-Werehene
Journal:  J Ovarian Res       Date:  2021-05-21       Impact factor: 4.234

4.  Clinical trials for COVID-19 should include sex as a variable.

Authors:  Evelyne Bischof; Jeannette Wolfe; Sabra L Klein
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

5.  Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia.

Authors:  Jun Mi; Weimin Zhong; Chaoqun Huang; Wanwan Zhang; Li Tan; Lili Ding
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

6.  Sex Differences and COVID-19.

Authors:  Natalie Thomas; Caroline Gurvich; Jayashri Kulkarni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons.

Authors:  Amir Tajbakhsh; Khojaste Rahimi Jaberi; Seyed Mohammad Gheibi Hayat; Mehrdad Sharifi; Thomas P Johnston; Paul C Guest; Mohammad Jafari; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Sex differences in COVID-19: the role of androgens in disease severity and progression.

Authors:  Mohamed S Mohamed; Thiago C Moulin; Helgi B Schiöth
Journal:  Endocrine       Date:  2020-11-11       Impact factor: 3.633

Review 9.  The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.

Authors:  Elahe Seyed Hosseini; Narjes Riahi Kashani; Hossein Nikzad; Javid Azadbakht; Hassan Hassani Bafrani; Hamed Haddad Kashani
Journal:  Virology       Date:  2020-09-24       Impact factor: 3.616

10.  Sex-Based Differences in COVID-19 Outcomes.

Authors:  Astha Tejpal; Eugenia Gianos; Jane Cerise; Jamie S Hirsch; Stacey Rosen; Nina Kohn; Martin Lesser; Catherine Weinberg; David Majure; Sanjaya K Satapathy; David Bernstein; Matthew A Barish; Alex C Spyropoulos; Rachel-Maria Brown
Journal:  J Womens Health (Larchmt)       Date:  2021-04       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.